BioCryst Reports Second Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to BioCryst Reports Second Quarter 2017 Financial Results

BioCryst Pharma (BCRX) Misses Q2 EPS by 2c

August 7, 2017 6:01 AM EDT

BioCryst Pharma (NASDAQ: BCRX) reported Q2 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $5.79 million.

Cash, cash equivalents and investments totaled $95.6 million at June 30, 2017, and reflect an increase from $65.1 million... More